Read moreA urine test for
prostate cancer?Read more

OUR MISSION

simplify, speed up and standardize the diagnostic-therapeutic path of the prostate cancer, with specific urine tests for screening, risk definition, monitoring of active surveillance and response to therapies

Specific

It measures molecules differently expressed in the urine of men with prostate cancer and healthy individuals

Rapid

It returns the result in a few minutes, during a normal urological visit

Easy to use

It does not require an analysis laboratory or even dedicated instrumentation: it is a point-of-care

ZenPSA-pro

A RAPID TEST FOR PROSTATE CANCER

The ZenPSA-pro evaluates the presence of two molecules in the urine and allows the specialist to reach a better assessment of the probability that the patient has prostate cancer and therefore of the need to proceed with more in-depth diagnostic tests, such as magnetic resonance, or invasive, as a prostate biopsy.

This device therefore aims to improve the diagnostic-therapeutic path for prostate cancer, offering itself to the specialist as a particularly simple, rapid and cost-effective early investigation tool.

The ZenPSA-pro is not currently available for sale, but only for clinical investigations.

ZenPSA-pro
Read more about the test

Two drops of urine to confirm or deny a suspicion

ZenPSA-pro is a simple urine test, in rapid test format, easy to use, which can be performed during a normal urological visit.
It is sufficient to collect a urine sample after rectal examination and apply two drops to the test.
No sample preparation or sending to a diagnostic laboratory is required.

It is sufficient to apply two drops of urine to the test and wait a few minutes.

Once the visit is completed, the urologist will be able to decide on the need for further tests based on the physical examination and the test result.

Who has already invested

NIB biotec has already received funding and investments from Italian and European institutions

EIT health
G-Factor 2020
PON ERDF

The latest on NIB biotec

innoweek nib biotecNIB biotec

NIB biotec tra le protagoniste di Innoweek 2026

brevetti NIB biotecNIB biotec

NIB biotec Patents Extended to Four Countries

7idee espresso nib biotecNIB biotec

NIB biotec selezionata per “Sette idee per cambiare l’Italia”

getit investor dayNIB biotec

NIB biotec selected to participate in the Get it! Investor Day

50 in a day nib biotecNIB biotec

NIB biotec al “50 in a Day”

nib biotec san franciscoNIB biotec

NIB biotec a San Francisco per INNOVIT

canada nib biotec brevettoNIB biotec

NIB biotec Granted Patent in Canada

NIB biotec at the AUA Innovation Nexus Showcase 2026

Milan longevity summit nib biotec

NIB biotec al Milan Longevity Summit 2026

NIB biotec selected for INNOVIT: a step toward the United States

zinco test rapidoNIB biotec

Il sensore colorimetrico per lo zinco alla base di ZenPSA-pro

lituania nib biotecNIB biotec

NIB biotec in Vilnius: Prostate Cancer Prospects in Lithuania

,
EAU Helmut Haas Award 2026NIB biotec

EAU Helmut Haas Award 2026 for Urine Test for Prostate Cancer

medtech innovator nib biotecNIB biotec

NIB biotec at the MedTech Innovator Radar Forum 2026

EAU26 prostataNIB biotec

At EAU 2026 the studies on urinary biomarkers for prostate cancer

European Cancer ScreeningNIB biotec

Cancer screening is being reviewed in Brussels

longevity world forum nib biotecNIB biotec

NIB biotec on stage at the Longevity World Forum 2026

health.tech nib biotecNIB biotec

NIB biotec at the Health.tech Global Summit 2026

Get It 2026NIB biotec

NIB biotec selezionata per Get it!

best abstract SIUNIB biotec

The PSA Paradox Among the Best Abstracts at SIU 2025

china NIB biotec

NIB biotec at the China-Italy Science, Technology and Innovation Week 2025

SIU 2025 prostate

SIU 2025: Progress on prostate cancer in Sorrento

Innovation Day Life ScienceLazio Innova

NIB Biotec protagonist at Innovation Day Life Science 2025

aua nexus bootcamp 2025NIB biotec

NIB Biotec at Boot Camp Innovation Nexus 2025

frontiers health italy

Frontiers Health Italy 2025: innovation and early diagnosis at the centre

Innovation Fair 2025

NIB biotec at the Innovation Fair 2025: A Bridge Between Europe and Africa

AUA Innovation nexus prostate

NIB Biotec at the AUA Innovation Nexus Bootcamp 2025

nib biotec patent china japanGenerated with AI

NIB Biotec Granted Patent in Japan and China

hlth 2025 nib biotec

NIB biotec flies to Amsterdam for HLTH Europe 2025

Rome Startup Week

NIB biotec at Rome Startup Week 2025

AUA25 congress

AUA 2025 Congress: Urological Innovations in Las Vegas

carola lauritano nib biotecNIB biotec

Carola Lauritano is the new Clinical Trial Manager of NIB Biotec

UAE 2025 NIB biotec

EAU Congress 2025: Latest Results of NIB Prostate Cancer Test

innostars spice nib biotec

NIB Biotec Selected for EIT Health InnoStars SPICE

dxpx NIB biotecNIB biotec

NIB biotec on stage at DxPx 2025 in Munich

africa europe prostate cancer

NIB Biotec at the AU-EU Innovation Agenda Workshop on Public Health Innovations

eit health Innostars connect

NIB biotec on the podium of InnoStars Connect

innostars gran final

NIB Biotec at the InnoStars Awards Grand Final

africa europe Innovation agenda

NIB Biotec for Innovation in Public Health in Africa

frontiers health 2024 nib biotechttps://www.frontiers.health/

NIB Biotec on stage at Frontiers Health 2024

Simona Corinti nib biotecNIB biotec

Simona Corinti joins NIB Biotec

EIT health innostars connect nib biotec

NIB Biotec selected for EIT Health InnoStars Connect

cluadio talmelli

Claudio Talmelli joins the board of NIB biotec

Francesca Gallo nib biotec

Francesca Gallo joins the NIB biotec team

American Urology association congress 2024

Our urine test at AUA 2024

Best innovative device of the yearNIB biotec

Best innovative device of the year

Europe man webinar

Europe Man webinar: urine tests for screening and active surveillance

Healthy Longevity Catalyst AwardeesNIB biotec

NIB biotec at the Healthy Longevity Catalyst Awards 2023

wild card nib biotec

NIB Biotec wins EIT Health's Wild Card 2022 programme

Unicredit StartLab 2021

NIB biotec selected for Unicredit StartLab 2021

Sergio Occhipinti VeronesiNIB biotec

A research project for prostate cancer

PrecSucc
123456789101112131415161718